EJCTS Click here for details of sales representative
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


  Click here to read this article as a CME activity


Eur J Cardiothorac Surg 2009;35:214-228. doi:10.1016/j.ejcts.2008.11.003
Copyright © 2009, European Association for Cardio-thoracic Surgery. Published by Elsevier. All rights reserved.

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Francesco Nicolini
Tiziano Gherli
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nicolini, F.
Right arrow Articles by Gherli, T.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Nicolini, F.
Right arrow Articles by Gherli, T.
Related Collections
Right arrow Congestive Heart Failure
Right arrow Extracorporeal circulation
Right arrow Mechanical Circulatory Assistance


Reviews

Alternatives to transplantation in the surgical therapy for heart failure

Francesco Nicolini*, Tiziano Gherli

Heart Surgery Section, Department of Surgical Sciences, University of Parma Medical School, Italy

Received 20 May 2008; received in revised form 10 October 2008; accepted 7 November 2008.

* Corresponding author. Address: Sezione di Cardiochirurgia, Università degli Studi di Parma, Via A. Gramsci 14, 43100 Parma, Italy. Tel.: +39 0 521 703270; fax: +39 0 521 293196. (Email: francesconicolini{at}libero.it).

Despite considerable improvements in the medical treatment of heart failure (HF), the gold standard for the treatment of these patients remains heart transplantation. Nevertheless, in consideration of the shortage of organ donors, this procedure can be offered only to a small percentage of patients who could benefit from a new heart. A number of innovative approaches are being investigated in terms of improved survival and quality of life in patients refractory to medical therapy and excluded from cardiac transplantation lists. These procedures include the optimization of medical therapy, coronary artery bypass surgery and valve surgery in high-risk patients, ventricular restoration techniques, and the implantation of ventricular assist devices as destination therapy. Future therapies for HF could include stem cell therapy, associated with standard revascularization techniques or with other procedures such as ventricular assist devices implantation or ventricular restoration techniques, allowing the potential differentiation of implanted stem cells in a resting and unloaded heart. The modern approach to surgical treatment of HF is multidisciplinary, given that the number of alternative available options to heart transplantation requires a close collaboration between both cardiologists and cardiac surgeons in treating patients with end-stage HF who are not candidates for transplant.

Key Words: Heart failure • Surgery • Cardiomyopathy







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2009 European Association for Cardio-Thoracic Surgery. Published by Elsevier. All rights reserved.